Title:
PHARMACEUTICAL COMPOSITION CONTAINING ANTI-INTEGRIN α11 ANTIBODY FOR TREATMENT OR PREVENTION OF AGING-RELATED DISEASES
Document Type and Number:
WIPO Patent Application WO/2023/238845
Kind Code:
A1
Abstract:
The present invention provides a novel pharmaceutical composition that is for treating or preventing aging-related diseases and utilizes the selective removal of senescent cells. A pharmaceutical composition containing anti-integrin α11 (ITGA11) antibodies as an active component is administered to a subject.
Inventors:
UCHINO HIROSHI (JP)
Application Number:
PCT/JP2023/020932
Publication Date:
December 14, 2023
Filing Date:
June 06, 2023
Export Citation:
Assignee:
ASTELLAS PHARMA INC (JP)
International Classes:
A61K39/395; A61P3/10; A61P13/12; A61P43/00; C07K16/18
Domestic Patent References:
| WO2019168176A1 | 2019-09-06 | |||
| WO2021127500A1 | 2021-06-24 |
Foreign References:
| JP2010514413A | 2010-05-06 | |||
| CA2985274A1 | 2019-05-10 | |||
| JP2020525021A | 2020-08-27 | |||
| JP2020511674A | 2020-04-16 |
Attorney, Agent or Firm:
YAMAMOTO, Osamu et al. (JP)
Download PDF: